{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:31:28Z","timestamp":1790663488562,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jid.2020.07.011","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T02:28:55Z","timestamp":1596076135000},"page":"575-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous Leishmaniasis"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-0384","authenticated-orcid":false,"given":"Fernanda O.","family":"Novais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8481-5471","authenticated-orcid":false,"given":"Ba T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-0653","authenticated-orcid":false,"given":"Phillip","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.07.011_bib1","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/rheumatology\/kez175","article-title":"Tofacitinib modulates the VZV-specific CD4+ T cell immune response in\u00a0vitro in lymphocytes of patients with rheumatoid arthritis","volume":"58","author":"Almanzar","year":"2019","journal-title":"Rheumatology (oxford)"},{"key":"10.1016\/j.jid.2020.07.011_bib2","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2003-01-0183","article-title":"IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in\u00a0vitro","volume":"102","author":"Alves","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jid.2020.07.011_bib3","doi-asserted-by":"crossref","first-page":"eaax4204","DOI":"10.1126\/scitranslmed.aax4204","article-title":"Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis","volume":"11","author":"Amorim","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2020.07.011_bib4","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"Arevalo","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jid.2020.07.011_bib5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjd.14871","article-title":"Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial","volume":"175","author":"Bissonnette","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2020.07.011_bib6","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.4049\/jimmunol.159.9.4467","article-title":"Parasite-driven in\u00a0vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis","volume":"159","author":"Brodskyn","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/jiz538","article-title":"Granzyme B produced by natural killer cells enhances inflammatory response and contributes to the immunopathology of cutaneous leishmaniasis","volume":"221","author":"Campos","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jid.2020.07.011_bib8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/IAI.02404-14","article-title":"Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection","volume":"83","author":"Cardoso","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.jid.2020.07.011_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8+ T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2020.07.011_bib10","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/s41467-019-12017-8","article-title":"Lung endothelial cell antigen cross-presentation to CD8+T cells drives malaria-associated lung injury","volume":"10","author":"Claser","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.07.011_bib11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/annrheumdis-2015-208267","volume":"75","author":"Conaghan","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2020.07.011_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/imm.13173","article-title":"Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8+ T cells in human cutaneous leishmaniasis","volume":"159","author":"Covre","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2020.07.011_bib13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","article-title":"Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy","volume":"151","author":"Craiglow","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2020.07.011_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2016.09.006","article-title":"Tofacitinib for the treatment of alopecia areata and variants in adolescents","volume":"76","author":"Craiglow","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2020.07.011_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jid.2020.07.011_bib16","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.1500855","article-title":"Lymphocytic choriomeningitis virus expands a population of NKG2D+CD8+ T cells that exacerbates disease in mice coinfected with Leishmania major","volume":"195","author":"Crosby","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003970","article-title":"Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection","volume":"10","author":"Crosby","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2020.07.011_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jdcr.2016.10.009","article-title":"Idiopathic erythema multiforme: evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib","volume":"2","author":"Damsky","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2020.07.011_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2567.2008.02941.x","article-title":"Interleukin 21 up-regulates perforin-mediated cytotoxic activity of human intra-epithelial lymphocytes","volume":"127","author":"Ebert","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2020.07.011_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-3024.2009.01125.x","article-title":"Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis","volume":"31","author":"Faria","year":"2009","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis","volume":"367","author":"Fleischmann","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.07.011_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/JLB.5RI0218-084R","article-title":"Translational and clinical advances in JAK-STAT biology: the present and future of jakinibs","volume":"104","author":"Gadina","year":"2018","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2020.07.011_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9440(10)65585-X","article-title":"Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance","volume":"153","author":"Gebhard","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2020.07.011_bib25","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","article-title":"An early history of T cell-mediated cytotoxicity","volume":"18","author":"Golstein","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib27","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.18295\/squmj.2019.19.01.015","article-title":"The role of tofacitinib in the management of alopecia totalis","volume":"19","author":"Hernandez-Montoya","year":"2019","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.jid.2020.07.011_bib28","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.4049\/jimmunol.175.12.8003","article-title":"IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation","volume":"175","author":"Janas","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41591-018-0117-4","article-title":"Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes","volume":"24","author":"Junqueira","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2020.07.011_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.186.7.989","article-title":"Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice","volume":"186","author":"K\u00e4gi","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2020.07.011_bib31","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3389\/fimmu.2019.02917","article-title":"Cytotoxic T cell-derived granzyme B is increased in severe Plasmodium falciparum Malaria","volume":"10","author":"Kaminski","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib32","doi-asserted-by":"crossref","first-page":"e89776","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2020.07.011_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamadermatol.2017.5778","article-title":"Rapid repigmentation of vitiligo using tofacitinib plus low-dose, narrowband UV-B phototherapy","volume":"154","author":"Kim","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2020.07.011_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/rheumatology\/kex068","article-title":"Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study","volume":"56","author":"Kubo","year":"2017","journal-title":"Rheumatology (oxford)"},{"key":"10.1016\/j.jid.2020.07.011_bib35","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.celrep.2020.01.099","article-title":"Type I interferons suppress anti-parasitic immunity and can be targeted to improve treatment of visceral leishmaniasis","volume":"30","author":"Kumar","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2020.07.011_bib36","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1056\/NEJMoa1310476","article-title":"Tofacitinib versus methotrexate in rheumatoid arthritis","volume":"370","author":"Lee","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.07.011_bib37","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.jisp.2017.10.003","article-title":"Tofacitinib for the treatment of severe alopecia areata in adults and adolescents","volume":"19","author":"Liu","year":"2018","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jid.2020.07.011_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib39","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1086\/340526","article-title":"Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer","volume":"34","author":"Machado","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jid.2020.07.011_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2020.07.011_bib41","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1073\/pnas.1610253113","article-title":"Network pharmacology of JAK inhibitors","volume":"113","author":"Moodley","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2020.07.011_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006196","article-title":"CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1\u03b2 production","volume":"13","author":"Novais","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2020.07.011_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003504","article-title":"Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis","volume":"9","author":"Novais","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2020.07.011_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/jid.2014.305","article-title":"Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology","volume":"135","author":"Novais","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jid.2020.07.011_bib45","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaci.2004.12.077","article-title":"Interleukin-15 induces superior cytotoxic lymphokine activated killer cells in\u00a0vitro with higher perforin, granzyme B, and cytokine expressions","volume":"115","author":"\u00d6zdemir","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gutjnl-2016-312735","article-title":"Tofacitinib for induction and maintenance therapy of Crohn\u2019s disease: results of two phase IIb randomised placebo-controlled trials","volume":"66","author":"Pan\u00e9s","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jid.2020.07.011_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jid.2020.07.011_bib48","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/eji.200535290","article-title":"Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells","volume":"36","author":"Rausch","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib49","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1172\/JCI133474","article-title":"CD8+ T cells target cerebrovasculature in children with cerebral malaria","volume":"130","author":"Riggle","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.07.011_bib50","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.cgh.2014.01.029","article-title":"A\u00a0phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn\u2019s disease","volume":"12","author":"Sandborn","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jid.2020.07.011_bib51","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.07.011_bib52","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/jid.2013.4","article-title":"CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFN\u03b3(+)-mediated parasite killing in human cutaneous leishmaniasis","volume":"133","author":"Santos Cda","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.07.011_bib53","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/L16-0125","article-title":"Reversal of alopecia universalis by tofacitinib: a case report","volume":"165","author":"Scheinberg","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jid.2020.07.011_bib54","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2020.07.011_bib55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","article-title":"Janus kinase inhibitors in dermatology: a systematic review","volume":"76","author":"Shreberk-Hassidim","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2020.07.011_bib57","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.1201730","article-title":"IL-21 promotes CD8+ CTL activity via the transcription factor T-bet","volume":"190","author":"Sutherland","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cyto.2006.11.008","article-title":"Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal","volume":"36","author":"Tamang","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.jid.2020.07.011_bib59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1084\/jem.20071887","article-title":"Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15","volume":"206","author":"Tang","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2020.07.011_bib60","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1084\/jem.20150303","article-title":"Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease","volume":"212","author":"Tang","year":"2015","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2020.07.011_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/icb.2015.89","article-title":"Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes","volume":"94","author":"Trivedi","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jid.2020.07.011_bib62","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4269\/ajtmh.2009.80.574","article-title":"Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil","volume":"80","author":"Unger","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jid.2020.07.011_bib63","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20040172","article-title":"Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells","volume":"199","author":"Uzonna","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2020.07.011_bib64","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.07.011_bib65","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or adalimumab versus placebo in rheumatoid arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.07.011_bib66","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib67","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2020.07.011_bib68","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/1744666X.2019.1607298","article-title":"Tofacitinib for the treatment of rheumatoid arthritis: an update","volume":"15","author":"Yamaoka","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/cimm.1996.0293","article-title":"Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes","volume":"174","author":"Ye","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib70","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI85996","article-title":"IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection","volume":"126","author":"Younes","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.07.011_bib71","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.4049\/jimmunol.143.12.3994","article-title":"In\u00a0vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice","volume":"143","author":"Young","year":"1989","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.07.011_bib72","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2217\/imt-2018-0113","article-title":"Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis","volume":"11","author":"Zhang","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jid.2020.07.011_bib73","doi-asserted-by":"crossref","first-page":"102424","DOI":"10.1016\/j.jaut.2020.102424","article-title":"JAK\/STAT signaling controls the fate of CD8+CD103+ tissue-resident memory T cell in lupus nephritis","volume":"109","author":"Zhou","year":"2020","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2020.07.011_bib74","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/08916934.2011.593599","article-title":"Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo","volume":"44","author":"Zloza","year":"2011","journal-title":"Autoimmunity"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20319424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20319424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:20:31Z","timestamp":1758302431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20319424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0022202X20319424"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.07.011","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}